Computerised cognitive training combined with nutritional counseling in mild cognitive impairment - results of a 2 × 2 factorial randomized controlled trial (BrainFit-nutrition study).
Alzheimer's research & therapy · 2026
Abstract originale
BACKGROUND: Computerized cognitive training (CCT) and nutritional interventions may improve cognitive functioning in individuals with mild cognitive impairment (MCI). This study investigated whether a combination of CCT and online nutritional counseling can improve global cognition in individuals with MCI. We also evaluated differences between MCI-specified and active control versions of the interventions. METHODS: In this 2 × 2 factorial randomized controlled trial (BrainFit-Nutrition study), conducted fully remotely, participants in Germany with a psychometric diagnosis of MCI (age 60+) were randomized into four groups (Intention to treat, n = 270). For each intervention, one MCI specified and one active control version were developed (cognition: individualized CCT (iCCT) vs. basic CCT (bCCT); nutrition: whole-food plant-based nutrition (WFPB) vs. German Nutrition Society (DGE)). At baseline and after six months, cognitive functioning was assessed with the Montreal Cognitive Assessment (MoCA; primary outcome: change after six months). A mixed-model ANCOVA (t0-t6, complete case strategy (CC), n = 228) was applied for the main analysis. RESULTS: All four groups achieved a significant improvement of approximately 2 points on the MoCA after six months. Estimated marginal means varied from M = 2.44 (iCCTxDGE) to M = 1.77 (iCCTxWFPB), notably without significant group differences. The 2 × 2 mixed ANCOVA revealed a significant main effect of time (F = 3.96, p = 0.048, partial η2 = 0.018). The specific content of the respective modalities being compared (iCCT vs. bCCT; WFPB vs. DGE-oriented counseling) did not appear to make a relevant group difference with regard to the primary outcome. After 6 months, 55% of all participants reached non-MCI values on the MoCA. CONCLUSION: The results of this study suggest, that in people with MCI, notable improvement in global cognition can be achieved in a six-months intervention period. When CCT is combined with digital nutritional counseling, the form of intervention - whether elaborate or basic - apparently did not modify the outcome; rather, this data set suggests that it is worthwhile to proactively undertake something in both domains. Future clinical studies in mixed-methods-designs, including usual-care comparators, basic science study modules, qualitative aspects and health economic variables are warranted to gain a better understanding of mechanisms, sustainability of effects, clinical relevance, and cost-effectiveness. TRIAL REGISTRATION: ISRCTN10560738; registered 11/23/2021.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Computerised cognitive training combined with nutritional counseling in mild cognitive impairment - results of a 2 × 2 factorial randomized controlled trial (BrainFit-nutrition study)
Background
Computerized cognitive training (CCT) and nutritional interventions may improve cognitive functioning in individuals with mild cognitive impairment (MCI). This study investigated whether a combination of CCT and online nutritional counseling can improve global cognition in individuals with MCI. We also evaluated differences between MCI-specified and active control versions of the interventions.
Methods
In this 2 × 2 factorial randomized controlled trial (BrainFit-Nutrition study), conducted fully remotely, participants in Germany with a psychometric diagnosis of MCI (age 60+) were randomized into four groups (Intention to treat, n = 270). For each intervention, one MCI specified and one active control version were developed (cognition: individualized CCT (iCCT) vs. basic CCT (bCCT); nutrition: whole-food plant-based nutrition (WFPB) vs. German Nutrition Society (DGE)). At baseline and after six months, cognitive functioning was assessed with the Montreal Cognitive Assessment (MoCA; primary outcome: change after six months). A mixed-model ANCOVA (t0-t6, complete case strategy (CC), n = 228) was applied for the main analysis.
Results
All four groups achieved a significant improvement of approximately 2 points on the MoCA after six months. Estimated marginal means varied from M = 2.44 (iCCTxDGE) to M = 1.77 (iCCTxWFPB), notably without significant group differences. The 2 × 2 mixed ANCOVA revealed a significant main effect of time (F = 3.96, p = 0.048, partial η2 = 0.018). The specific content of the respective modalities being compared (iCCT vs. bCCT; WFPB vs. DGE-oriented counseling) did not appear to make a relevant group difference with regard to the primary outcome. After 6 months, 55% of all participants reached non-MCI values on the MoCA.
Conclusion
The results of this study suggest, that in people with MCI, notable improvement in global cognition can be achieved in a six-months intervention period. When CCT is combined with digital nutritional counseling, the form of intervention – whether elaborate or basic – apparently did not modify the outcome; rather, this data set suggests that it is worthwhile to proactively undertake something in both domains. Future clinical studies in mixed-methods-designs, including usual-care comparators, basic science study modules, qualitative aspects and health economic variables are warranted to gain a better understanding of mechanisms, sustainability of effects, clinical relevance, and cost-effectiveness.
Trial registration
ISRCTN10560738; registered 11/23/2021.
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1186/s13195-026-02255-6.
Background
Before persons’ health condition progress to dementia, they often suffer from mild cognitive impairment (MCI) [1, 2]. Therefore, MCI is likely a crucial period for intervention to avoid conversion to dementia. Since available pharmacological treatments for early Alzheimer’s disease show standardized mean differences below 0.25 over a treatment period of at least one year, non-pharmacological treatment options are of clinical interest [3, 4]. There are well-established medical and psychosocial risk factors for dementia [5], offering starting points for dementia prevention [6, 7], including cognitive training or cognitive stimulation [8, 9], physical exercise [10–12], and an anti-inflammatory diet [13–16]. A combination of such approaches as a multicomponent intervention may also be beneficial for individuals suffering from cognitive impairment [17–21].
Cognitive training is recommended as a non-pharmacological intervention due to its beneficial effects, especially in early stages of dementia, such as the MCI stage [22]. Cognitive training stimulates neuroplasticity, task-dependent brain activation, and brain metabolism [9]. Thus, cognitive training may prevent or delay the onset of dementia [22, 23]. In the current decade, cognitive training has increasingly been performed digitally [9, 23, 24], enabling barrier-reduced access and thereby offering an effective alternative to analogous exercises [25, 26]. Computerized cognitive training (CCT) comprises computer-based tasks that include cognitive exercises, games, and virtual reality with real-time feedback [27] and is well-accepted among people with MCI [27, 28]. CCT can implement adaptive learning systems for custom-tailored levels of task difficulty, with positive effects on different outcomes [9, 24]. In addition, well-designed game elements and higher gamification levels may increase effectiveness, adherence, and motivation for optimized training success likelihoods [29]. Meta-analyses have shown a small but significant positive effect of CCT on global cognition and specific cognitive functions compared with control groups (CGs), especially when compared with passive CGs [23, 26, 29]. A relative lack of high-quality studies in people with MCI still poses a substantial limitation [26, 30], indicating a need for optimized intervention doses and adapted, individualized programs.
In a previous study we developed an individualized CCT (iCCT), specialized for people with MCI [31, 32]. The iCCT integrated various cognitive parameters—e.g., information processing speed, short-term memory, and decision making—in a playful manner and AI-based dynamically adapted task difficulty. As a counterpart, we constructed the basic CCT (bCCT), which is characterized by fewer exercises, simpler exercises, and no use of AI. The results of the MCI-CCT study showed that using iCCT or bCCT three times a week for about 30 min led to significant improvement within six months in global cognition (MoCA score) in people with MCI living at home [32], with a significantly greater increase in the iCCT group. The BrainFit-Nutrition study (BF-N) extended this study design by including an additional intervention: online nutritional counseling.
Healthy dietary patterns are associated with preserved cognitive function [13, 16, 33–36]. Diets such as the Mediterranean Diet (MedDiet), the MIND Diet (Mediterranean-DASH Intervention for Neurodegenerative Delay), and the DASH Diet (Dietary Approaches to Stop Hypertension) emphasize minimally processed plant foods and have been linked to reduced inflammation and a lower risk of cognitive decline and dementia [15, 37–40]. A whole-food plant-based (WFPB) diet represents a more challenging dietary approach compared with such diets due to its emphasis on minimally processed plant-based foods and the restriction of animal products. Although evidence for the effectiveness of the Mediterranean and MIND diets exists, there are still limited results from controlled studies specifically examining WFPB interventions for MCI.
Importantly, WFPB differs from Mediterranean, MIND, and DASH dietary patterns in that it excludes or strongly restricts animal-derived products rather than primarily moderating their intake. Although Mediterranean and MIND dietary patterns currently have a stronger evidence base for cognitive outcomes in older adults, WFPB counseling was chosen as the MCI-specified nutritional intervention based on the hypothesis that a more pronounced dietary shift might produce stronger mechanistic effects. The potential cognitive benefits of WFPB nutritional patterns may be attributed to several interacting pathways, including reduction of vascular and metabolic risks such as hypertension, diabetes, hyperlipidemia, obesity, and cardiovascular disease [41–47], anti-inflammatory and antioxidant effects through reduced intake of saturated animal fats, heme iron, processed meat, and animal proteins combined with higher intake of fiber, polyphenols, and phytochemicals [48–55], and neurobiological mechanisms such as improved endothelial function, cerebrovascular perfusion, and insulin signaling in the brain [41, 51–55]. Thus, WFPB was used as a more focused nutritional contrast to DGE-oriented healthy-diet counseling, while the latter represented an active, evidence-based healthy omnivorous comparator rather than a passive or usual-diet control.
Clinical interventions indicate that plant-based diets may improve diabetes outcomes [42, 43], coronary heart disease [44, 45], and overweight, and even modest weight reduction has been associated with better attention and memory performance [46, 47]. Reduced consumption of animal proteins [48], alongside high intake of dietary fiber and phytochemicals/-nutrients [49, 50], may contribute via anti-inflammatory processes. Since MCI has also been linked to microinflammatory processes [51], bioactive compounds derived from plants, fungi, and algae may be particularly relevant [52–55]. A recent randomized pilot trial of a comprehensive multidomain lifestyle intervention comprising a WFPB diet, moderate aerobic exercise, stress management, and enhanced social support reported improvements in cognition in individuals with MCI or early Alzheimer’s disease [56]. It should be noted that this trial tested a combined lifestyle program, not a WFPB dietary intervention in isolation. Its findings therefore constitute evidence for multicomponent lifestyle change that includes WFPB, rather than standalone dietary evidence [56].
Thus, both CCT and nutrition may improve the cognitive capacities of people with MCI. Thus, in the BF-N study, we developed one MCI-specified version of the intervention for each component (iCCT & online counseling focusing on a WFPB diet) and corresponding active controls (bCCT & online counseling focusing on a diet aligned with recommendations for healthy nutrition by the German Nutrition Society (in German: Deutsche Gesellschaft für Ernährung, DGE). Previous papers from this trial cohort have included baseline analyses of daily activities [57], depression [58], the risk factor of alcohol consumption [59], as well as follow-up data on user experiences with CCTs [60] and longitudinal data on dietary behavior and adherence data [61].
Aim of the study
The primary aim of this 2 × 2 randomized controlled trial (RCT) was to test whether the MCI-specified versions of the cognitive and nutritional interventions produced greater improvement in the cognitive abilities, measured with the Montreal Cognitive Assessment (MoCA) than their active control versions, and whether the combination of the MCI-specified versions resulted in an additional interaction effect in individuals with MCI over a six-months intervention period [62]. We considered three study hypotheses:
Primary hypothesis I: iCCT leads to statistically significantly greater improvements in global cognition during the six-months intervention period compared with bCCT.
Primary hypothesis II: Online nutritional group counseling focusing on a WFPB diet leads to statistically significantly greater improvements in global cognition during the six-months intervention period compared with online nutritional group counseling focusing on a healthy diet recommended by the DGE.
Secondary hypothesis: iCCT in combination with online nutritional group counseling, focusing on a WFPB diet, has a positive interaction effect. The combination of these two versions of the interventions will show more improvement in global cognition than all other groups during the six-months intervention period in people with MCI.
Methods
Study design
The BF-N study was a prospective 2 × 2 factorial RCT that was conducted completely remotely [62]. Each intervention comprised an MCI specified version of the intervention and an active control version. The study included people living in Germany with psychometrically diagnosed MCI. The first participant entered the study on 01/25/2022, and the last patient completed t6 on 05/09/2023. The intervention period was six months, with a follow-up after another six months (t12). The data were collected at baseline (t0) and directly after the intervention period (t6) as well as after 12 months (t12). However, the current analysis focused on the pre-post intervention results (t0-t6), follow-up data will be reported elsewhere.
All procedures were approved by the Ethics Committee of the Friedrich-Alexander-Universität Erlangen-Nürnberg (Ref. 21–318_1-B). Participation was voluntary, and participants were free to leave the study at any time for any reason. Written informed consent was obtained from all participants. The study was prospectively registered on 11/23/2021 at ISRCTN registry (Trial identification number: ISRCTN10560738; https://doi.org/10.1186/ISRCTN10560738). Further details on the study design are available in the study protocol [62].
Recruitment
The a priori sample size calculation indicated a sample size of n = 200, evenly distributed across the four groups, to achieve a power of f ≥ 0.24, taking into account α = 0.05, β = 0.20, a correlation between repeated measures of 0.5, and a non-sphericity correction of 1 [62]. Various methods were used to recruit study participants and to fulfill the calculated sample size: In addition to advertising by two German health insurance companies, we initiated social media activities on Facebook and advertised the study in the print editions and websites of various magazines and newsletters. Furthermore, memory clinics throughout Germany were included in the recruitment process. In addition, Bavarian pharmacies were made aware of the study in two newsletters in collaboration with the Bavarian State Chamber of Pharmacists (Bayerische Landesapothekerkammer). Furthermore, the study was advertised in Berlin as part of advertisements for public transportation alongside with other research projects by the Berlin working group.
Eligibility of participants
Participants had to meet several inclusion criteria to participate in the BF-N study. During the online-screening, interested participants were screened for basic cognitive functions, including a personal consultation regarding the results of the screening. Individuals who met the inclusion criteria were informed about the eligibility of study participation and invited to participate [62].
Inclusion criteria were: (1) MCI, psychometrically operationalized by a global cognition score on the Montreal Cognitive Assessment (MoCA) ≤24 (cut-off for cognitive impairment) and at the same time a score on the Mini-Mental State Examination (MMSE) ≥24 (cut-off for no dementia), (2) possession of a computer (Windows/Linux/MacOS) with microphone and camera, laptop, or tablet with access to the internet and basic skills in their use, (3) age ≥ 60, and (4) informed consent. Exclusion criteria were: (1) completely blind or deaf, (2) no personal computer, laptop, or tablet with access to the internet, (3) normal cognition, operationalized by a score of global cognition on the MoCA > 24, (4) dementia, operationalized by a score on the MMSE < 24, (5) acute depression, operationalized by a score on the 9-item Patient Health Questionnaire (PHQ-9) ≥12, or (6) other psychiatric or neurologically diagnosed diseases (checklist) [62].
Randomization and blinding
After completed screening process and written informed consent, participants were randomly assigned to one of the four intervention groups. Randomization was performed externally by the Institut für Medizininformatik, Biometrie und Epidemiologie (IMBE) of the Friedrich-Alexander-Universität Erlangen-Nürnberg. The statistician was blinded to the groups. Due to the rolling recruitment, we performed a block randomization to one of the four study groups, stratified by gender, age, and baseline global cognition (MoCA), with variable block sizes [62]. People from the same household were assigned to the same group. After randomization, the IMBE transmitted the final group allocation to the study headquarters. Participants were then provided with an access link and a serial number for the CCT program based on their group assignment (iCCT vs. bCCT). Participants’ assignment to the respective intervention group was masked by using non-specific wording (e.g., “brain food” and “cognitive training”). The student assistants conducting the outcome assessment were blinded to participants’ group allocation at all times. Before the last randomization block, we checked that the randomization balance was adequate.
Interventions
Type I: Cognition with computerized cognitive training
The two computerized applications (intervention and active control) were available for Windows, MacOS, and Linux PC/laptop and Android tablet. More information on the CCT and users’ experiences with it have already been published [60, 62].
Version Ia: iCCT for people with MCI
The ten game-based exercises (e.g. applying rules, pattern recognition) included in this training application were selected to meet the performance levels expected from people with MCI based on an adaptive difficulty level. The iCCT address the basic parameters of information processing and short-term memory and require different types of decision making. Using machine learning, each participant is provided with exercises tailored to their individual skill level. Detailed information on the machine learning system are already published [62]. The application selects the highest difficulty level that the participant is likely to solve as entry level. During the training phase the machine learning system generates the ideal difficulty level of training for each participant using cognitive test parameters that are assessed individually once a month. Thus, the iCCT aims to enhance the positive effects of CCT by providing exercises at the difficulty level that is most suitable for each participant.
Version Ib: bCCT (active control)
The bCCT includes four exercises on the basis of quizzes and visual tasks (e.g. rotating picture quiz, quiz-show). They are designed to be “playful” and require simple strategies as well as long-term memory. The starting difficulty of the exercises is based solely on the participant’s previous success with this exercise. Machine learning methods are not implemented. The aim of the bCCT is to offer the active control group an enjoyable computerized leisure activity with a limited number of cognitive tasks. For more information see study protocol [62].
Type II: Nutrition via online nutritional group counseling
The nutritional intervention was implemented as a six-months online group counseling program. Sessions were conducted via a pseudonymized online conference tool. Groups of 10–25 participants attended twelve 90-minute bi-weekly counseling-sessions, each following a standardized format: a brief introduction, a structured educational component (e.g., basics of healthy eating, nutrient groups, mindful eating), practical skill-building (e.g., meal planning, virtual cooking demonstrations), and a closing segment with goal setting and homework. Courses were led by three qualified nutritionists with training in group facilitation [61]. To support adherence, participants received monthly food boxes with products consistent with their dietary recommendations, serving as an implementation strategy to facilitate transfer of counseling content into everyday practice [61].
Participants were randomized to one of two dietary counseling approaches:
Version IIa: Counseling focusing on a whole-food plant-based diet, WFPB
This program promoted a predominantly WFPB-pattern (vegetables, whole grains, legumes, fruits, nuts, seeds) with no energy restrictions, emphasizing foods with potential neuroprotective properties (e.g., green leafy vegetables, berries, soy products, turmeric, green tea, omega-3-rich oils). Participants were encouraged to avoid animal products and minimize highly processed foods, red and processed meats, refined grains, and sugary beverages. Importantly, the WFPB protocol differed from the Mediterranean, MIND, and DASH diets in that it excluded or strongly restricted animal-derived products rather than moderating their intake. At baseline, 95.5% of WFPB-group participants reported following an omnivorous diet [63]. The program thus entailed a substantial change in dietary habits.
Version IIb: Counseling focusing on a diet recommended by the German nutrition society, DGE (active control)
This program followed DGE recommendations for a balanced omnivorous diet, encouraging daily vegetables, fruits, and whole grains alongside moderate amounts of fish, poultry, lean meat, dairy, and eggs, while limiting saturated fat, added sugars, and highly processed items. The DGE-based counseling was delivered in the same format as the WFPB-arm. At baseline, 94.6% of DGE-group participants reported following an omnivorous diet [61], consistent with the program’s optimization rather than fundamental change of current eating patterns. The DGE guidelines constitute a scientifically validated, evidence-based dietary reference standard, and therefore represent an active comparator rather than an inactive control [63].
Measures
The participants were interviewed at baseline and after the intervention phase (after six months) by videoconference. The fulfilment of the baseline data after checking the study eligibility and willingness to participate was conducted by telephone interview.
Primary outcome
Montreal Cognitive Assessment (MoCA): The MoCA is a performance test that screens for MCI and assesses global cognition status [64]. It consists of more difficult items than the MMSE and is therefore better able to detect MCI [64–67]. A score ≤ 24 (range 0–30 points) indicates cognitive impairment [68, 69]. Parallel versions of the German translation of the MoCA for videoconferencing were used in the study to eliminate learning effects: V.8.1 was administered at t0 (screening) and V.8.2 at t6.
Screening instruments
Mini-Mental Status Examination (MMSE): The MMSE is the most frequently used screening test for dementia [70], with five areas of cognitive functioning: orientation, registration, attention and calculation, recall, and language. A score ≤ 23 (range 0–30 points) indicates a dementia syndrome, whereas scores > 23 are interpreted as no dementia [71]. For this study, we used an adapted validated version of the MMSE for an audio-visual setting based on Timpano et al. [72, 73].
Patient Health Questionnaire − 9 items (PHQ-9): The PHQ-9 is a short self-assessment screening tool for depression, often used in primary care settings [74]. It consists of nine items covering the nine DSM-IV criteria by asking patients about their experiences during the last two weeks. The items are rated on a four-point scale ranging from 0 (not at all) to 3 (nearly every day). The total sum score indicates varying levels of depression. A cut-off ≥12 was found to show a good balance between sensitivity and specificity [75].
Other variables - Sociodemographic and health-related data
The student assistants used a standardized questionnaire to assess sociodemographic and health-related data as well as modifiable risk factors for MCI. Sociodemographic data were recorded at baseline and comprised information on age, sex, marital status, highest education level (as assessed with the ISCED [76]), employment status, monthly income, and household size. Furthermore, as modifiable risk factors for MCI, the status of general mental activities, physical activities, social participation, sleeping habits, average liquid intake, eating habits, alcohol consumption, nicotine consumption, and visual and hearing capacity were assessed at baseline and t6. Health-related data, which were also recorded at baseline, and—if relevant—at t6 and t12, comprised information on diseases, medication, body weight, body height, and dementia cases in the family.
To assess the effects and side effects on brain function (i.e., stimulation or sedation) of prescribed medication taken by the participants, we used the “medication score” [77]. All effects were ranked from −2 (strong sedating effect) to + 2 (strong stimulating effect) by two clinical pharmacologists at the Uniklinikum Erlangen and summed to form the medication score.
To measure the individual vascular risk level, we calculated the vascular risk score, which represents the number of risk factors consisting of smoking, hypertension, hypercholesterolaemia, and diabetes mellitus. The score ranges from 0 (no vascular risk factors) to 4 (four vascular risk factors).
To analyze the comorbidity-related mortality rate, we used the Charlson Comorbidity Index, updated and validated by Quan et al. [78]. To form the index, 12 diseases are assigned weights ranging from 1 point (e.g., chronic pulmonary disease) to 6 points (e.g., metastatic solid tumor). The sum score ranges from 0 to 24 points. Higher scores indicate a higher one-year comorbidity-related mortality rate, whereby a score of 5 is associated with an 85% one-year mortality risk.
The frequency of participation in the cognitive training program was assessed on the basis of self-reported training frequency (minutes/day), number of training days/week, and number of monthly uploads (adherence CCTB, sum score 1–7). The frequency of participation in the online nutritional counseling courses was assessed per session (nutrition adherence, sum score 0–12). For both adherence variables, the number of participants attending every nutritional counseling session or every CCTB upload was documented. Furthermore, each participant was asked by telephone about the occurrence of adverse events (AE) to assess safety. If participants reported an AE, they were asked about its intensity and progression in detail. The study center evaluated the causal relationship with the intervention, recommended actions, and whether a severe adverse event (SAE) had occurred.
Data collection
Psychology students were trained at the study headquarters in Erlangen to collect data in semi-structured interviews with the study participants with MCI.
Data were collected at baseline (t0) and immediately after the end of the intervention (t6). The cognition-related parameters were collected approximately two weeks before t0 during the screening procedure and thus used as baseline data. The data were collected digitally by student assistants via video surveys using the certified software samedi (Samedi GmbH, paid access for video consultation licenses and a widget for appointment booking at t0 and t6) or telephone interview (t0). They were blinded to participants’ group assignments at all times. Data were collected with the RedCap software, which enabled a plausibility check of the data to be carried out directly during data collection using the programmed variable ranges. In addition, the CCTB [79] was recorded on the participants’ digital devices and voluntarily made available to the Erlangen study headquarters by the participants via digital upload to a data-secure cloud.
In addition to the sealed envelope containing the MoCA and MMSE documents, the participants received a questionnaire with sociodemographic as well as health-related questions for the examination appointments, including the PHQ-9 to record depressive symptoms.
Digital participant management was carried out by the webMODYS software (provided by Leibniz Institute for Prevention Research and Epidemiology—BIPS, Bremen, Germany), which was individually programmed for the project and hosted at Uniklinikum Erlangen.
Statistical analysis
According to the study protocol [62], the analysis should have been conducted using intention-to-treat (ITT) and per-protocol analyses; however, this analysis strategy was modified after start of the interventions. Due to a dropout rate of 15.6% between baseline and t6 follow-up, and taking into account current developments in the statistical analysis of pharmacological RCTs on dementia prevention, which favor a modified ITT approach [80], the complete case (CC) analysis was established as the primary analysis strategy. The originally planned ITT strategy was instead conducted as a sensitivity analysis to test the robustness of the CC results against the ITT model, which contains 15.6% estimated data for the primary outcome variable. The per-protocol analysis specified in the study protocol was not performed because no operationalized adherence criteria had been defined prior to the start of the study.
Thus, the analysis sample comprised n = 228 cases in the main analysis (CC), and n = 270 people in the sensitivity analysis (ITT). To enable the ITT analysis, 42 (15.6%) missing MoCA t6 values (primary outcome: cognition) were imputed by applying the expectation maximization algorithm (E-M-algorithm) with group, MoCA score at t0, and all available t0 variables (Table 1) as predictors.Table 1Baseline characteristics of the study participants in the complete case sample (N = 228)
Variables iCCT+WFPB(n = 55) iCCT+DGE(n = 59) bCCT+WFPB(n = 54) bCCT+DGE(n = 60) p Groupdifference(│effect size│) Total(n = 228)
Sociodemographics
Age (years), M (SD) 70.6 (6.6) 71.0 (6.5) 70.3 (5.8) 70.9 (7.8) 0.951 0.01$ 70.7 (6.7)
Sex (female), n (%) 29 (52.7) 31 (52.5) 26 (48.1) 33 (55.0) 0.907 0.05# 119 (52.2)
Education level (ISCED)1, n (%) 0.566 0.09#
Low/middle 21 (38.2) 22 (37.3) 26 (48.1) 22 (36.7) 91 (39.9)
High 34 (61.8) 37 (62.7) 28 (51.9) 38 (63.3) 137 (60.1)
Household net income per month (Euro), M (SD) 2646 (702) 2453 (815) 2625 (720) 2690 (623) 0.302 0.02$ 2602 (720)
Employment (yes), n (%) 17 (30.1) 16 (27.2) 14 (25.9) 17 (28.3) 0.946 0.04# 64 (28.1)
Other people living in the household (yes), n (%) 39 (70.9) 39 (66.1) 42 (77.8) 38 (63.3) 0.365 0.12# 158 (69.3)
MoCA Baseline, M (SD) 22.27 (1.55) 22.32 (1.60) 22.35 (1.62) 22.28 (1.47) 0.993 0.01$ 22.31 (1.55)
MoCA t6, M (SD) 24.11 (3.17) 24.68 (2.54) 24.43 (2.57) 24.35 (2.81) 0.749 0.01$ 24.39 (2.77)
Risk factors for cognitive decline
Depressiveness (PHQ-92), M (SD) 3.7 (2.8) 3.9 (2.8) 3.7 (2.7) 4.0 (3.2) 0.923 0.01$ 3.8 (2.9)
Vascular risk (sum score3), M (SD) 1.0 (0.82) 1.13 (0.87) 1.04 (0.92) 1.12 (0.90) 0.818 0.01$ 1.08 (0.87)
Smoking (last 30 days, yes), n (%) 5 (9.1) 1 (1.7) 2 (3.7) 3 (5.0) 0.421 0.12# 11 (4.8)
Hypertension (yes), n (%) 23 (41.8) 29 (49.2) 20 (37.0) 31 (51.7) 0.378 0.12# 103 (45.2)
Hypercholesterolaemia (yes), n (%) 24 (43.6) 30 (50.8) 27 (50.0) 26 (43.3) 0.772 0.07# 107 (46.9)
Diabetes (yes), n (%) 3 (5.5) 7 (11.9) 6 (11.1) 7 (11.7) 0.617 0.09# 23 (10.1)
Medication score4, M (SD) −0.05 (0.3) −0.07 (0.25) −0.11 (0.57) −0.08 (0.33) 0.880 0.01$ −0.08 (0.38)
Cognitive activities (hours per week), M (SD) 15.6 (9.9) 17.9 (9.4) 17.5 (12.8) 21.6 (22.1) 0.159 0.03$ 18.2 (14.7)
Physical activities (hours per week), M (SD) 9.8 (6.4) 11.8 (9.9) 10.5 (8.9) 10.7 (8.3) 0.649 0.01$ 10.7 (8.5)
Social activities (hours per week), M (SD) 8.8 (6.6) 11.6 (9.9) 9.0 (5.5) 10.9 (8.4) 0.148 0.02$ 10.1 (8.0)
Charlson Index5, M (SD) 0.16 (0.42) 0.34 (0.73) 0.37 (0.73) 0.37 (0.74) 0.314 0.02$ 0.31 (0.67)
Body Mass Index, normal (≥19 and ≤25)6 (yes), n (%) 49 (89.1) 52 (88.1) 47 (87.0) 53 (88.3) 0.990 0.02# 201 (88.2)
Interventions
Adherence to nutritional counseling7, M (SD) 7.2 (3.7) 7.6 (3.9) 7.6 (3.5) 7.4 (3.8) 0.916 0.01$ 7.4 (3.7)
Full adherence to nutritional counseling8, n (%) 11 (20.0) 13 (22.0) 13 (24.1) 11 (18.3) 0.889 0.05# 48 (21.1)
Adherence to CCTB (months) 9, M (SD) 5.5 (2.3) 5.8 (2.1) 5.9 (1.9) 5.7 (2.0) 0.624 0.01$ 5.7 (2.1)
Full adherence to CCTB8, n (%) 38 (69.1) 46 (78.0) 45 (83.3) 46 (76.7) 0.366 0.12# 175 (76.8)
Note. $ η2; # Cramer’s V; iCCT: individualized computerized cognitive training; bCCT: basic computerized cognitive training; WFPB: whole-food plant-based nutritional counseling; DGE: nutritional counseling as recommended by the German Nutrition Society; 1 In the low education category, there were only n = 7 cases in three groups as determined by the ISCED (International Standard Classification of Education), so these cases were combined with the medium ISCED category; 2 Patient Health Questionnaire 9; 3 Number of vascular risk factors: range 0 (no vascular risk factor) to 4 (four vascular risk factors); 4 Sedating (<0) or stimulating (>0) effect or side effect of the prescribed medications: sum score for each medication, which was ranked from −2 (strong sedating effect) to + 2 (strong stimulating effect); 5 Updated Charlson Comorbidity Index: range: 0–24; 6 normal range of the Body Mass Index; 7 adherence captured through the number of counseling sessions attended; 8number of participants attending each nutritional counseling session or every CCTB (Computerized Cognitive Test Battery [79]), upload; 9 number of months with active upload of the CCTB
In the first part of the statistical analysis framework, the characteristics of the sample and group differences are described using inferential statistical procedures and their effect sizes: Cramer’s V (crosstabs), Cohen’s d (t-test), and η2 (ANOVA/ANCOVA). The interpretation of the effect sizes and the decision about which variables to include were based on Cohen’s guidelines [81]: Cramer’s V with limits of 0.1 (low), 0.3 (medium), and 0.5 (high); Cohen’s d with limits of 0.2 (low), 0.5 (medium), and 0.8 (high); and η2 with limits of 0.010 (low), 0.059 (medium), and 0.138 (high).
The inferential statistical procedures we used were χ2-tests, t-tests, and 2 × 2 ANCOVAs. Differences between the groups in the CC and ITT samples were analyzed for categorically scaled variables with the χ2-test and for continuous variables with ANOVAs. The change in the global cognition score between t0 and t6 was analyzed with a t-test for dependent samples in the total sample as well as in the four intervention groups (iCCT + WFPB, iCCT + DGE, bCCT + WFPB, and bCCT + DGE).
The main analysis for testing the three hypotheses (two primary and one secondary hypothesis) was conducted with a 2 × 2 mixed ANCOVA for the dependent variable global cognition (MoCA) using the within-subject factor time (t0, t6) and the between-subject factor group (Intervention Type I: cognitive intervention iCCT vs. bCCT and Intervention Type II: nutrition intervention WFPB vs. DGE). Furthermore, the model was adjusted for relevant baseline variables as covariates. Variables were included as relevant covariates if they had an evidence-based [82] preventive influence on the pathological decline of cognition and showed a relevant effect (>small effect size) of the group difference in the study sample. To rule out multicollinearity, the covariates were allowed to correlate with each other with a maximum of p = 0.80 [83, 84]. Within a sensitivity analysis, the main analysis was also conducted for the ITT sample (I). The procedure was the same as for the main analysis.
Furthermore, we assessed the reversion rate from MCI (MoCA score ≤ 24) to normal cognition (MoCA > 24, MCI criterium psychometrically not fulfilled) in the primary outcome (MoCA score) as well as the occurrence of AEs on a descriptive level. The reversion rate for individuals at the cutoff threshold to cognitive normal (MoCA 22–24) was examined separately.
Results
Screening and participant flow
Between January and September 2022, a total of 1,111 people aged 60 or older living at home were screened for eligibility (Fig. 1). About 71% (n = 785) were excluded because they did not meet inclusion criteria. The inclusion criteria were met by N = 326 individuals, n = 271 gave informed consent to take part in the study, were randomized into 19 blocks, and were allocated to the four intervention groups (Fig. 1). Since balance had been achieved in relation to the nutritional intervention before the last randomization, no adjustments were made in the last block. One person did not complete the baseline data and was therefore excluded from the ITT sample (final nITT = 270). At the end of the intervention period after six months, n = 228 individuals participated in the follow-up assessment (CC sample). The drop-out rate between baseline and t6 was 15.6%.
Sample characteristics
The CC sample is characterized as follows: They were on average 70.7 years old (Range 60–86 years), and 52% were female (Table 1). Baseline global cognition showed a mean of 22.31 (SD = 1.55) on the MoCA scale. According to the International Standard Classification of Education (ISCED [76]), 60% had a high educational level. About half of the participants reported hypertension or hypercholesterolemia. Nevertheless, with an average of 1.08 vascular risk events, the vascular risk score was low in the study sample. The one-year mortality risk was very low in the study population, as 88% (n = 201) had Charlson comorbidity scores of 0.
Most of the effect sizes were statistically irrelevant—less than 0.1 for Cramer’s V or less than 0.02 for η2—except for monthly household net income, smoking, hypertension, weekly cognitive activities, weekly social activities, Charlson comorbidity index, and shared household. There were no significant differences between the sample characteristics of the CC sample and the ITT sample (see Supplementary Material).
Intervention exposure (adherence)
In Intervention Type I, the iCCT tended to be used more frequently than the bCCT: The iCCT was used for an average of 35.8 min/training day (SD = 10.6), 2.95 days/week (SD = 1.6), corresponding to approx. 111 min/week. The bCCT was used for an average of 35.6 min/training day (SD = 10.8, p = 0.432), 2.71 days/week (SD = 1.2, p = 0.098), corresponding to 105 min/week. However, the bCCT tended to be used over a longer period of the intervention than the iCCT (5.8 months vs. 5.6 months, p = 0.262). Therefore, no significant differences could be found between the use of iCCT vs. bCCT.
In Intervention Type II, the WFPB group participated in an average of 7.5 out of 12 online nutritional counseling courses (62.5%, SD = 3.6), while the DGE group participated in 7.4 out of 12 courses (61.7%, SD = 3.8), with no significant differences between the two versions of this type of intervention (p = 0.425).
Descriptive change in global cognition
In the descriptive analysis, the change in global cognition from t0 to t6 (difference variable t6-t0) was examined in the total sample. The assumptions for performing t-tests for dependent samples were fully met: There were no extreme outliers in the data, and a normal distribution could be assumed on the basis of the central limit theorem. Cognitive abilities as captured by the MoCA were significantly higher at t6 (M = 24.39, SD = 2.77) than at t0 (M = 22.31, SD = 1.55; 95%-CI (t6-t0): [1.74; 2.43]; t(227)=11.96, p < 0.001) in the total sample (n = 228). This increase (d = 0.79) reflects a large effect size according to Cohen [81].
Table 2 provides a summary of the changes in global cognition within each intervention group.Table 2Course of global cognition within each intervention group at baseline and six-months-follow-up
Group T0, M (SD) T6, M (SD) 95%-CI (t6-t0) t-test p d
iCCT+WFPB (n = 55) 22.27 (1.55) 24.11 (3.17) [1.01; 2.66] 4.48 <0.001 0.60
iCCT+DGE (n = 59) 22.32 (1.60) 24.68 (2.54) [1.68; 3.04] 6.95 <0.001 0.90
bCCT+WFPB (n = 54) 22.35 (1.62) 24.43 (2.57) [1.40; 2.74] 6.13 <0.001 0.83
bCCT+DGE (n = 60) 22.28 (1.47) 24.35 (2.81) [1.44; 2.69] 6.59 <0.001 0.88
Note. Effect sizes (Cohen’s d) as specified by Cohen [81]
Main analysis (primary outcome)
As part of the main analysis, a 2 × 2 mixed ANCOVA was computed, with time (t0 vs. t6) as the within-subjects factor and intervention type (version of cognitive training [iCCT/bCCT] and version of nutritional counseling [WFPB/DGE]) as the between-subjects factors. Furthermore, seven baseline variables met the criteria to be included as covariates in the model: monthly household net income (η2 = 0.02), social activities (η2 = 0.02), cognitive activities (η2 = 0.03), Charlson comorbidity index (η2 = 0.02), smoking (V = 0.12), hypertension (V = 0.12), and household situation (V = 0.12). Baseline MoCA score was included as another variable in the model in order to be able to evaluate time effects (η2 = 0.01). The strongest correlation was observed between both adherence factors (r = 0.607, p < 0.001), so multicollinearity could be excluded.
When using the adjusted means, all four intervention groups showed a significant increase in the global cognition score (MoCA) from baseline to follow-up (p < 0.001), with no significant between group differences. Figure 2 shows the estimated marginal means for the group ×time interaction (MoCA score).
The ANCOVA analysis revealed no significant between-group differences for the comparison between the two cognition groups (pcognition = 0.891), between the two nutrition groups (pnutrition = 0.992), and between the four groups with the specific combination of one cognition and one nutrition intervention (pcognition ×nutrition = 0.367; see Table 3). After adjusting for the covariates (Table 3), there was a small but significant main effect of time (F = 3.96, p = 0.048, partial η2 = 0.018). The time ×group interaction was not significant for the version of CCT (iCCT vs. bCCT) or the version of nutritional counseling (WFPB vs. DGE) or across all four intervention groups (pcognition = 0.902; pnutrition = 0.488; pcognition × nutrition = 0.270). The results of the sensitivity analysis (ITT sample) did not significantly differ from those of the main analysis in the CC sample: There was also only a significant main effect of time (see Table 3).Table 3Results of the 2 × 2 mixed-model ANCOVA examining the between subject effects and the within-subject effects on global cognition (MoCA score) in the CC and ITT sample
CC sample (N = 228) ITT sample (N = 270)
Effect F p Partial η2 M~(SE) 95%-CI~ F p Partial η2 M~(SE) 95%-CI~
Between subject effects
Cognition version#, ^ 0.02 0.891 0.000 0.03 (0.25) [−0.46; 0.53] 0.02 0.901 0.000 0.03 (0.23) [−0.42; 0.47]
Nutrition version●, ^ 0.00 0.992 0.000 −0.01 (0.25) [−0.50; 0.50] 0.30 0.584 0.001 −0.13 (0.23) [−0.57; 0.32]
Cognition version × nutrition version^^ 0.82 0.367 0.003 0.82 0.367 0.003
iCCT-WFPB 1.77 (0.38) [1.03; 2.52] 1.69 (0.32) [1.06; 2.33]
iCCT-DGE 2.44 (0.35) [1.74; 3.14] 2.36 (0.32) [1.73; 2.99]
bCCT-WFPB 2.14 (0.38) [1.39; 2.88] 1.97 (0.31) [1.37; 2.58]
bCCT-DGE 1.99 (0.36) [1.28; 2.69] 1.85 (0.31) [1.25; 2.45]
Within-subject effects
T$ 3.96 0.048 0.018 7.07 0.008 0.027
T x household net income+, - 0.68 0.409 0.003 0.73 0.395 0.003
T x social activities* 0.16 0.687 0.001 0.20 0.653 0.001
T x cognitive activities* 0.93 0.337 0.004 0.98 0.323 0.004
T x Charlson index§ 0.11 0.738 0.001 0.15 0.702 0.001
T x smoking- 2.26 0.135 0.011 2.05 0.153 0.008
T x hypertension- 0.25 0.621 0.001 0.38 0.538 0.002
T x shared household- 1.21 0.272 0.006 2.13 0.146 0.008
T x cognition version# 0.02 0.902 0.000 0.12 0.726 0.000
T x nutrition version● 0.38 0.488 0.002 0.74 0.391 0.003
T x cognition version ×nutrition version 1.22 0.270 0.006 1.57 0.212 0.006
Note. df = 1 for all effects; ~group differences as well as 95% CI are only reported for the between group effects; ^the difference between the two groups of each type of intervention (cognition or nutrition); ^^ time differences within each intervention combination. $ T: time; + income per month; - dichotomous variable; * recorded in hours per week; § Updated Charlson Comorbidity Index, range: 0–24; # cognition version: individualized CCT (iCCT) vs. basic CCT (bCCT); ● nutrition version: whole-food plant-based (WFPB) nutrition vs. nutrition recommended by the German Nutrition Society (DGE); significant p-values are printed in bold
Reversion rates
The descriptive analysis of the reversion rates showed that, at baseline, all study participants scored in the MCI range (MoCA score ≤ 24, inclusion criterion). After the 6-months intervention phase, 55% (n = 125) of participants left the psychometrically determined MCI range. Within the subgroup of people nearest to the cut-off threshold to cognitive normal at baseline (MoCA t0 = 22–24; n = 168), 62% (n = 104) reverted to cognitive normal after six months intervention (M = 1.91; SD = 2.45). For a detailed breakdown by group, see Table 4.Table 4Reversion rates within the MoCA among the total sample as well as the subsample with high MoCA t0 (22–24)
iCCT+WFPB, n(%) [95%-CI]^ iCCT+DGE, n(%) [95%-CI]^ bCCT+WFPB, n(%) [95%-CI]^ bCCT+DGE, n(%) [95%-CI]^
Total CC sample (n = 228) 26 (47.3) [33.6;60.9] 34 (57.6)
[44.6;70.6]
32 (59.3)
[45.7;72.8]
33 (55.0) [42.0;68.0]
Subgroup t0-MoCA 22–24 (n = 168) 22 (53.7) [37.7;69.6] 27 (61.4) [46.4;76.3] 27 (64.3)
[49.2;79.4]
28 (68.3)
[53.4; 83.2]
Note. CC = complete case – main analysis strategy. ^95%-CI belongs to the percentage rate
There were no significant differences in the reversion rates to MoCA > 24 between the four randomized groups in the total sample (χ2 = 1.88; p = 0.597) as well as in the subsample MoCA t0 = 22–24 (χ2 = 2.00; p = 0.573).
Safety (adverse events)
During the six-months intervention phase in total 55 SAEs and AEs occurred in 45 participants. Eight SAEs appeared in seven study participants (lung cancer, prostatitis, cardiac arrhythmia, falls (2), pain (2), adhesive ileus). All SAEs were classified as not related to the study intervention. Nevertheless, they were reported more often in the cognitive active control groups (bCCT: 6) than in the cognitive intervention groups (iCCT: 2; bCCT-WFPB: 3, bCCT-DGE: 3, iCCT-WFPB: 1, iCCT-DGE: 1).
Further, 34 individuals reported 42 AEs. However, these were not related to the study intervention (e.g., influenza, COVID-19 infection, … ). In addition, five study participants reported an unintentional weight loss of approximately 2–3 kg as a result of changing their diet in accordance with the nutritional recommendations. These AEs occurred mostly in the nutritional intervention group (bCCT-WFPB: 3, bCCT-DGE: 1). This weight loss is not considered clinically critical.
Research hypothesis
In notable contrast to the hypotheses, no differences were observed between the MCI specified versions and the active control versions within the two types of interventions (primary hypotheses I+II). In particular, the combination of the two MCI specified versions of each type of intervention (iCCT and WFPB) showed no advantage over the other groups (secondary hypothesis). However, there was a significant improvement in global cognition from t0 to t6 in all four intervention groups.
Discussion
Aim of this RCT was to examine the effects on global cognition of combining two different types of interventions—CCT along with a nutritional counseling. Both were available in an MCI specified version (iCCT or WFPB diet) and an active control version (bCCT or DGE diet). Study participants were randomized to one of the four intervention groups in a 2 × 2 design.
Contrary to the a priori hypotheses, we found no evidence of differential change from the CCT format, dietary counseling format, or their interaction. During the six-months intervention period, global cognition improved by 2.1 points on the MoCA across all intervention groups. This finding is consistent with the multivariate result of a significant main effect of time. Since there were no differences in the therapy dose between the two versions of intervention per intervention type (approx. 110 min CCT, approx. 7.5 of 12 nutritional counseling group sessions), the therapy dose does not need to be taken into account when comparing the results between the groups. Both types of interventions appear to be safe, as no SAEs related to the study interventions were reported. From a pragmatic implementation perspective, the similar cognitive outcomes across all four active intervention arms suggest that less complex (and potentially better scalable) intervention formats may warrant further evaluation as options for low-threshold community-based MCI management. However, this trial was designed as a superiority trial and did not include a pre-specified equivalence or non-inferiority margin; therefore, the absence of significant between-group differences cannot be interpreted as evidence of equivalent effectiveness. Future pragmatic, non-inferiority and larger scale clinical trials including health-economic studies are warranted to examine whether lower-complexity or less restrictive intervention formats such as bCCT and DGE-based counseling may provide comparable clinical benefit with lower implementation burden and barriers.
Due to the recruitment method and the digital requirements for participation, the educational level of most study participants was above average, which is not unusual in intervention studies using digital tools with older people with MCI [23]. Participants showed a high activation level at baseline in the three areas in which cognitive decline can be prevented: cognitive, physical, and social activities. Therefore, the sample was likely highly motivated to prospectively minimize the limitations they experienced from MCI, in the sense of a self-optimization process. This introduces bias and may limit the effects that can be achieved from additional interventions - in the sense of a ceiling effect - and may have rendered group differences less likely to occur.
Comparison of cognition-related results with the pilot study
In contrast to the pilot study [32], whose study design was expanded in the present RCT to include online nutritional counseling as one type of intervention, no significant group differences revealed in the present study. Compared with the pilot study, two findings emerged: (a) The average increase of 2.1 points in the MoCA score (within six months) from using the iCCT program—in combination with an online nutritional counseling—was roughly the same as in the pilot study (2.0 points). (b) The same increase of an average of 2.1 points in the MoCA score in six months when using the bCCT was about twice as large as in the pilot study (0.9 points). It is possible that combining the cognitive therapy with an online nutritional counseling boosted the effect of the bCCT in this sample of educated, motivated study participants so that the increase in the MoCA score was just as large as under the iCCT, which was also combined with an online nutrition program.
Compared with the pilot study [32], the improvement in the present study cannot be attributed to any specific combination of the two types of interventions. Thus, combining the cognitive intervention with the second intervention component (nutritional counseling) likely may have resulted in a more general lifestyle change for the participants.
Learning effects and spontaneous remission
The study attempted to avoid learning effects as much as possible in relation to the primary endpoint of general cognitive performance, as measured by the MoCA: a six-months intervention period was between the two measurement points, a time period that reduces learning effects in individuals with confirmed amnestic MCI [85], and a parallel version of the MoCA was used in the present study at t6. Nevertheless, the possibility of a learning effect cannot be completely ignored [86]. Furthermore, it should also be taken into account that no performance test is 100% reliable. In healthy older adults the reliable change index of the MoCA has a range of four points over 12 months [87]. However, this “noise” due to measurement uncertainty does not account for systematic changes over time, since reliability limitations occur at every measurement point. Also, it cannot be excluded that the statistical artifact of regression toward the mean may have influenced the change in cognitive performance in the MCI sample [88].
There are varying results regarding spontaneous remissions in MCI, as remission rates across different studies range from 5% [89] to 50% [90]. Most studies report a rate of around 12% to 20% [91–93]. According to Canevelli et al. [94], these differences, with 8% in clinical-based studies and 25% in population-based studies, can also be attributed to the study setting. Yu et al. [93] reported a remission rate of 18%, such that reverters were younger than stable MCI patients and differed in terms of clinical parameters. Compared with individuals with stable normal cognition, MCI reverters were older, tended to be female, had fewer years of schooling, and differed in terms of various clinical parameters. In addition, the cut-off value of ≤ 24 points on the MoCA used in the present study can be assumed to have a specificity of around 80% [69], which corresponds to a false-positive rate of about 20%. In the present study, however, the remission rate to psychometrically recorded, cognitively unremarkable values in all four groups was 45% to 59%, which is significantly higher than the average spontaneous remission rates between 8 and 25% in a recent review and meta-analysis [94] of up to 20% reported in the literature. The higher reversion rate within the subgroup MoCA 22–24 could be explained by the fact that these individuals were closer to the cut-off point for cognitive normal than individuals with more severe cognitive impairments. From a clinical perspective, MCI represents a subjective and objective decline in cognition and function associated with an increased risk of disease progression [95]. Thus, an increase in cognitive impairment must be expected in the majority of cases. However, causal inference is substantially limited in the current study due to the absence of a non-intervention control group. Therefore, the reversion rate to “cognitive normal” resulting from the interventions in this study should be interpreted as a trend.
Comparison with other CCT results in the literature
Cognitive training, especially in its computerized form, has been shown to be an effective intervention for improving cognitive abilities in people with MCI [23, 26, 29]. Furthermore, cognitive training appears to be superior to other non-pharmacological interventions in terms of its effect on cognition [22]. However, since the different types of interventions examined in this study were previously studied in separate groups of participants, whereas each group of participants received a combined intervention in our study, the results are not comparable. In contrast to Tsiakiri et al. [9], we found a significant improvement in global cognition (measured by the MoCA) in the present study when cognitive training was combined with nutritional counseling. Tsiakiri et al., on the other hand, only found an effect in terms of maintaining cognitive abilities, measured with the Cambridge Cognitive Examination, in the intervention group. The non-intervention group, on the other hand, showed cognitive decline. Thus, the present CCT seems to have worked better for our participants than in the study by Tsiakiri et al. [9]. One reason for this finding could be that both versions of CCT in the present study provided a good user experience [60]. Such positive experiences are important for maintaining motivation and frequency of use on the part of users, thereby contributing to long-term training success [27]. However, when interpreting the results comparatively, it is necessary to acknowledge that comparability is limited because numerous different cognitive parameters were measured in the various studies [96].
Comparison with results from digital nutrition programs for individuals with MCI
Several factors may explain why no significant differences were observed between the WFPB and the DGE counseling conditions. First, the DGE-based program represents a health-promoting dietary pattern itself and therefore constitutes an active control condition, potentially resulting in a ceiling effect. Second, dietary behavior was assessed in a secondary analysis of the BF-N study [61], indicating that dietary changes occurred in both groups and that the overall contrast between the counseling formats remained modest. Third, an intervention period of six months may still be insufficient for dietary changes to translate into measurable differences in cognitive outcomes, particularly when assessed with screening instruments such as the MoCA. Specifically, the secondary dietary data analysis [61] found that while both groups improved dietary quality scores from baseline, the between-group difference in achieved dietary pattern remained small, reflecting the high standard of the DGE active comparator. The DGE-based program represented an active, evidence-based healthy-diet comparator rather than a passive or usual-diet control. This strong active comparator may have reduced the likelihood of detecting differential cognitive effects between the nutritional counseling arms and should be considered when interpreting the results.
Several nutritional studies and systematic reviews have suggested that dietary factors can influence cognitive performance in individuals with MCI and related disorders. For example, systematic evidence indicates that antioxidant-rich foods, omega-3 fatty acid supplementation, and multinutrient approaches may improve specific cognitive domains and cognition-related biomarkers in MCI, although effects on global cognition are inconsistent across studies [97]. Despite these indications of benefits, the current literature also highlights methodological limitations, including small sample sizes, heterogeneous intervention designs, and variability in cognitive outcome measures, which complicate definitive conclusions about the magnitude and consistency of diet-related effects on cognition [98].
Although digital nutritional interventions specifically targeting individuals with MCI remain scarce, the emerging literature has highlighted both the potential and the gaps in this domain. A recent protocol for a smartphone-based multidomain digital therapeutic that includes dietary planning demonstrated the feasibility of integrating nutrition into mobile interventions for MCI, though outcome data are not yet available [99].
Taken together, these findings suggest that while integrating nutritional counseling into digital interventions for MCI is conceptually promising, there is presently limited empirical evidence on cognitive outcomes from fully digitalized dietary programs. Future research from methodologically rigorous trials with cognitive endpoints is needed to clarify whether remote diet counseling or digital nutritional support tools can reliably influence cognitive trajectories in people with MCI.
Comparison with other multi-domain interventions
The literature shows, that multidomain interventions are superior to single-domain interventions [17, 19, 100, 101]. In particular, the combination of cognitive training and physical activity has proven to be effective, although they also did not find a significant group ×time interaction [101]. The combination of CCT and nutritional counseling in the previous study showed an improvement in cognitive abilities across all groups, comparable to the improvement observed in the intervention group of the single-domain cognitive based pilot study [32]. Therefore, while synergistic effects resulting from the combination of cognitive and nutrition-related measures in the active control interventions are plausible, they have not yet been demonstrated. In contrast to Choi et al. [102], the intensity of the active control group within the BrainFit-Nutrition study was comparable to the MCI-specific interventions.
Further, the results are also in line with the multidomain intervention study of Xu et al. [18], finding also no significant differences between groups, but significant effects over time in all three groups. Possible reasons for the lack of group differences include a trend toward the middle, natural progression of MCI, or additional interventions that were not recorded. This aspect could also be important for interpreting the results of this study, as the MCI individuals in this study were highly cognitively, physically, and socially active in their everyday lives.
Limitations
For ethical reasons, and on the basis of the results of the pilot study, we decided not to use a “real” control group. Therefore, it is not possible to compare the effectiveness of the interventions with an untreated course. The nutritional intervention consisted only of online nutritional group counseling; participants were free to decide whether and to what extent they would implement the recommendations. Since no personal data on participants’ use of the CCTs were transmitted, we had no objective data on the use of the CCTs. The training intensities reported in this study were based on subjective information with potential sources of bias that this subjectivity entails. Furthermore, the primary outcome was assessed with a screening instrument (MoCA) and when interpreting the results of this performance test, potential learning effects – even though parallel tests were used in the follow-up measurement of this study – and limitations in reliability must be taken into account. It might be possible to identify meaningful group differences by using extensive test batteries. Also, the inclusion criteria did not fully cover the clinical diagnostic criteria for MCI. Due to the recruitment process and, in particular, the minimum technical requirements for participation in the study, the sample had an above-average level of education, which could further limit the representativeness of the results. In addition, selection effects may have occurred due to the recruitment and willingness of participants to take part in two different types of interventions, meaning that more health-conscious individuals tended to participate in the study, thereby obscuring potential group differences. It is also important to mention at this point that, despite the innovative study design and the chosen data analysis strategy, due to the combination of CCT and nutritional counseling in all four study arms, ultimately no reliable statements about the effectiveness of the individual intervention components can be made.
Furthermore, the present manuscript does not include detailed dietary intake outcomes as part of the primary outcome analysis. Adherence to the nutritional intervention was operationalized as session attendance, which reflects counseling-format engagement but does not directly capture actual and individual dietary change. Dietary behavior was assessed using food-frequency questionnaires and has been reported in a pre-planned secondary analysis [61]. This analysis found that while both groups improved dietary patterns from baseline, the between-group contrast in actual dietary intake remained modest. This modest dietary contrast, combined with the fact that the DGE comparator constituted an active, evidence-based healthy-diet condition rather than a passive control, provides a plausible mechanistic explanation for the absence of significant differential cognitive outcomes. Future trials in this area should focus on including validated dietary assessment instruments and nutritional biomarkers as adherence or mechanistic measures alongside session attendance and patient reported outcome measures.
Conclusion
In conclusion, a combined remote program of CCT and online nutritional counseling was associated with significant improvement in MoCA scores over six months in individuals with MCI in all four study groups. Contrary to the primary hypotheses, the more MCI specified interventions did not outperform the basic variants of CCT and dietary counseling. The interaction of the two MCI specified versions of the interventions also showed no benefits. These findings suggest that, in a digitally literate and highly motivated MCI cohort, structured participation in a multimodal remote lifestyle program may be more relevant to short-term changes in MoCA scores than assignment to specific intervention conditions.
Future research
Based on Inui et al. [1], longer follow-up times covering a period up to five years are particularly valuable. Such data are currently being collected, beginning with a 12 months follow-up, followed by testing every year, and will be published later. Future trials should also include usual-care comparators, a separate analysis of the two intervention types, objective adherence and use measures, as well as biological endpoints to clarify mechanisms, sustainability of effects, and clinical relevance.
Electronic supplementary material
Below is the link to the electronic supplementary material.
References
1.Inui Y Ito K Kato T Longer-term investigation of the value of 18F-FDG-PET and magnetic resonance imaging for predicting the conversion of mild cognitive impairment to Alzheimer’s disease: a multicenter study J Alzheimers Dis 2017 60 3 877 87 28922157 10.3233/JAD-170395 Inui Y, Ito K, Kato T. Longer-term investigation of the value of 18F-FDG-PET and magnetic resonance imaging for predicting the conversion of mild cognitive impairment to Alzheimer’s disease: a multicenter study. J Alzheimers Dis. 2017;60(3):877–87.10.3233/JAD-170395 PMC5676852 28922157
2.Hu C Yu D Sun X Zhang M Wang L Qin H The prevalence and progression of mild cognitive impairment among clinic and community populations: a systematic review and meta-analysis Int Psychogeriatrics 2017 29 10 1595 608 10.1017/S1041610217000473 28884657 Hu C, Yu D, Sun X, Zhang M, Wang L, Qin H. The prevalence and progression of mild cognitive impairment among clinic and community populations: a systematic review and meta-analysis. Int Psychogeriatrics. 2017;29(10):1595–608.10.1017/S1041610217000473 28884657
3.Zeng B Tang C Wang J Yang Q Ren Q Liu X Pharmacologic and nutritional interventions for early Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials J Alzheimers Dis 2024 99 4 1 14 10.3233/JAD-240161 PMC11191524 38759015 Zeng B, Tang C, Wang J, Yang Q, Ren Q, Liu X. Pharmacologic and nutritional interventions for early Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials. J Alzheimers Dis. 2024;99(4):1–14.10.3233/JAD-240161 PMC11191524 38759015
4.Reuben DB Kremen S Maust DT Dementia prevention and treatment: a narrative review JAMA Intern Med 2024 184 5 563 72 38436963 10.1001/jamainternmed.2023.8522 Reuben DB, Kremen S, Maust DT. Dementia prevention and treatment: a narrative review. JAMA Intern Med. 2024;184(5):563–72.10.1001/jamainternmed.2023.8522 38436963
5.Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. The lancet. 2024;404 (10452):572–628.10.1016/S0140-6736(24)01296-0 39096926
6.Vu HT Nguyen HT Nguyen AT Effectiveness of non-pharmacological interventions for dementia among the elderly: a randomized controlled trial Geriatrics 2024 9 2 52 38667519 10.3390/geriatrics9020052 Vu HT, Nguyen HT, Nguyen AT. Effectiveness of non-pharmacological interventions for dementia among the elderly: a randomized controlled trial. Geriatrics. 2024;9(2):52.10.3390/geriatrics9020052 PMC11050290 38667519
7.Seok J-W, Kim G, Kim JU. Comparative efficacy of seven nonpharmacological interventions on global cognition in older adults with and without mild cognitive impairment: a network meta-analysis of randomized controlled trials. Scientific reports. 2024;14(1):8402.10.1038/s41598-024-58232-2 PMC11006946 38600212
8.Chan AT Ip RT Tran JY Chan JY Tsoi KK Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis NPJ Digit Med 2024 7 1 1 10.1038/s41746-023-00987-5 38172429 Chan AT, Ip RT, Tran JY, Chan JY, Tsoi KK. Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis. NPJ Digit Med. 2024;7(1):1.10.1038/s41746-023-00987-5 PMC10764827 38172429
9.Tsiakiri A Plakias S Vlotinou P Athanasouli P Terzoudi A Kyriazidou S Ιnnovative health promotion strategies: a 6-month longitudinal study on computerized cognitive training for older adults with minor neurocognitive disorders Eur J Investigation Health, Phychol Educ 2025 15 3 34 10.3390/ejihpe15030034 PMC11941254 40136773 Tsiakiri A, Plakias S, Vlotinou P, Athanasouli P, Terzoudi A, Kyriazidou S, et al. Ιnnovative health promotion strategies: a 6-month longitudinal study on computerized cognitive training for older adults with minor neurocognitive disorders. Eur J Investigation Health, Phychol Educ. 2025;15(3):34.10.3390/ejihpe15030034 PMC11941254 40136773
10.Nuzum H Stickel A Corona M Zeller M Melrose RJ Wilkins SS Potential benefits of physical activity in MCI and dementia Behavioral Neurol 2020 2020 7807856 10.1155/2020/7807856 PMC7037481 32104516 Nuzum H, Stickel A, Corona M, Zeller M, Melrose RJ, Wilkins SS. Potential benefits of physical activity in MCI and dementia. Behavioral Neurol. 2020;2020:7807856.10.1155/2020/7807856 PMC7037481 32104516
11.Guure CB Ibrahim NA Adam MB Said SM Impact of physical activity on cognitive decline, dementia, and its subtypes: meta-analysis of prospective studies Biomed Res Int 2017 2017 13 10.1155/2017/9016924 PMC5320071 28271072 Guure CB, Ibrahim NA, Adam MB, Said SM. Impact of physical activity on cognitive decline, dementia, and its subtypes: meta-analysis of prospective studies. Biomed Res Int. 2017;2017:13.10.1155/2017/9016924 PMC5320071 28271072
12.Veronese N Soysal P Demurtas J Solmi M Bruyère O Christodoulou N Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline Eur geriatric Med 2023 14 5 925 52 10.1007/s41999-023-00858-y PMC10587099 37768499 Veronese N, Soysal P, Demurtas J, Solmi M, Bruyère O, Christodoulou N, et al. Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline. Eur geriatric Med. 2023;14(5):925–52.10.1007/s41999-023-00858-y PMC10587099 37768499
13.Gutierrez L Folch A Rojas M Cantero JL Atienza M Folch J Effects of nutrition on cognitive function in adults with or without cognitive impairment: a systematic review of randomized controlled clinical trials Nutrients 2021 13 11 3728 34835984 10.3390/nu13113728 Gutierrez L, Folch A, Rojas M, Cantero JL, Atienza M, Folch J, et al. Effects of nutrition on cognitive function in adults with or without cognitive impairment: a systematic review of randomized controlled clinical trials. Nutrients. 2021;13(11):3728.10.3390/nu13113728 PMC8621754 34835984
14.Townsend RF Logan D O’neill RF Prinelli F Woodside JV McEvoy CT Whole dietary patterns, cognitive decline and cognitive disorders: a systematic review of prospective and intervention studies Nutrients 2023 15 2 333 36678204 10.3390/nu15020333 Townsend RF, Logan D, O’neill RF, Prinelli F, Woodside JV, McEvoy CT. Whole dietary patterns, cognitive decline and cognitive disorders: a systematic review of prospective and intervention studies. Nutrients. 2023;15(2):333.10.3390/nu15020333 PMC9865080 36678204
15.J-E Y Y-J K Y-J L S-J H J-W L Association of Mediterranean, high-quality, and anti-inflammatory diet with dementia in UK biobank cohort J Nutr Health Aging 2025 29 7 100564 10.1016/j.jnha.2025.100564 PMC12172995 40315790 J-E Y, Y-J K, Y-J L, S-J H, J-W L. Association of Mediterranean, high-quality, and anti-inflammatory diet with dementia in UK biobank cohort. J Nutr Health Aging. 2025;29(7):100564.10.1016/j.jnha.2025.100564 PMC12172995 40315790
16.Dove A, Dunk MM, Wang J, Guo J, Whitmer RA, Xu W. Anti-inflammatory diet and dementia in older adults with cardiometabolic diseases. JAMA Network Open. 2024;7(8):e2427125–2427125.10.1001/jamanetworkopen.2024.27125 PMC11320167 39133488
17.Jia M Hu F Hui Y Peng J Wang W Zhang J Effects of exercise on older adults with mild cognitive impairment: a systematic review and network meta-analysis J Alzheimers Dis 2025 104 4 980 94 40026008 10.1177/13872877251321176 Jia M, Hu F, Hui Y, Peng J, Wang W, Zhang J. Effects of exercise on older adults with mild cognitive impairment: a systematic review and network meta-analysis. J Alzheimers Dis. 2025;104(4):980–94.10.1177/13872877251321176 40026008
18.Xu Z, Zhang D, Yip B-K, Lee E-P, Poon P-M, Peters R, et al. Combined mind-body physical exercise, cognitive training, and nurse-led risk factor modification to enhance cognition among older adults with mild cognitive impairment in primary care: a three-arm randomised controlled trial. Lancet Healthy Longevity. 2025;6(4).10.1016/j.lanhl.2025.100706 40294622
19.Hsieh S-W Hsiao S-F Liaw L-J Huang L-C Yang Y-H Effectiveness of early multimodal non-pharmacological interventions in cognitive preservation in the elderly Am J Alzheimer’s Disease Other Dementias® 2024 39 15333175241256803 10.1177/15333175241256803 PMC11135089 38798013 Hsieh S-W, Hsiao S-F, Liaw L-J, Huang L-C, Yang Y-H. Effectiveness of early multimodal non-pharmacological interventions in cognitive preservation in the elderly. Am J Alzheimer’s Disease Other Dementias®. 2024;39:15333175241256803.10.1177/15333175241256803 PMC11135089 38798013
20.Gomez-Soria I Marin-Puyalto J Peralta-Marrupe P Latorre E Calatayud E Effects of multi-component non-pharmacological interventions on cognition in participants with mild cognitive impairment: a systematic review and meta-analysis Arch Gerontol Geriat 2022 103 104751 10.1016/j.archger.2022.104751 35839574 Gomez-Soria I, Marin-Puyalto J, Peralta-Marrupe P, Latorre E, Calatayud E. Effects of multi-component non-pharmacological interventions on cognition in participants with mild cognitive impairment: a systematic review and meta-analysis. Arch Gerontol Geriat. 2022;103:104751.10.1016/j.archger.2022.104751 35839574
21.Luo G Zhang J Song Z Wang Y Wang X Qu H Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia-A network meta-analysis of randomized controlled trials Front Aging Neurosci 2023 15 1131744 36967820 10.3389/fnagi.2023.1131744 Luo G, Zhang J, Song Z, Wang Y, Wang X, Qu H, et al. Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia-A network meta-analysis of randomized controlled trials. Front Aging Neurosci. 2023;15:1131744.10.3389/fnagi.2023.1131744 PMC10035791 36967820
22.Belleville S, Cuesta M, Bier N, Brodeur C, Gauthier S, Gilbert B, et al. Five-year effects of cognitive training in individuals with mild cognitive impairment. Alzheimer’s Dementia: Diagnosis, Assess Disease Monit. 2024;16(3):e12626.10.1002/dad2.12626 PMC11378074 39246830
23.Zhang H, Huntley J, Bhome R, Holmes B, Cahill J, Gould RL, et al. Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e027062.10.1136/bmjopen-2018-027062 PMC6701629 31427316
24.Hu M Wu X Shu X Hu H Chen Q Peng L Effects of computerised cognitive training on cognitive impairment: a meta-analysis J Neurol 2021 268 5 1680 88 10.1007/s00415-019-09522-7 31650255 Hu M, Wu X, Shu X, Hu H, Chen Q, Peng L, et al. Effects of computerised cognitive training on cognitive impairment: a meta-analysis. J Neurol. 2021;268(5):1680–88.10.1007/s00415-019-09522-7 31650255
25.Rute-Pérez S Rodríguez-Domínguez C Vélez-Coto M Pérez-García M Caracuel A Effectiveness of computerized cognitive training by virtrael on memory and executive function in older people: a pilot study Brain Sci 2023 13 4 684 37190649 10.3390/brainsci13040684 Rute-Pérez S, Rodríguez-Domínguez C, Vélez-Coto M, Pérez-García M, Caracuel A. Effectiveness of computerized cognitive training by virtrael on memory and executive function in older people: a pilot study. Brain Sci. 2023;13(4):684.10.3390/brainsci13040684 PMC10136793 37190649
26.Li R, Geng J, Yang R, Ge Y, Hesketh T. Effectiveness of computerized cognitive training in delaying cognitive function decline in people with mild cognitive impairment: systematic review and meta-analysis. J Med Internet Res. 2022;24(10):e38624.10.2196/38624 PMC9650579 36301590
27.Contreras-Somoza LM Irazoki E Toribio-Guzmán JM de la Torre-Díez I Diaz-Baquero AA Parra-Vidales E Usability and user experience of cognitive intervention technologies for elderly people with MCI or dementia: a systematic review Front Phychol 2021 12 636116 10.3389/fpsyg.2021.636116 PMC8100576 33967901 Contreras-Somoza LM, Irazoki E, Toribio-Guzmán JM, de la Torre-Díez I, Diaz-Baquero AA, Parra-Vidales E, et al. Usability and user experience of cognitive intervention technologies for elderly people with MCI or dementia: a systematic review. Front Phychol. 2021;12:636116.10.3389/fpsyg.2021.636116 PMC8100576 33967901
28.Arlati S Di Santo SG Franchini F Mondellini M Filiputti B Luchi M Acceptance and usability of immersive virtual reality in older adults with objective and subjective cognitive decline J Alzheimers Dis 2021 80 3 1025 38 33646164 10.3233/JAD-201431 Arlati S, Di Santo SG, Franchini F, Mondellini M, Filiputti B, Luchi M, et al. Acceptance and usability of immersive virtual reality in older adults with objective and subjective cognitive decline. J Alzheimers Dis. 2021;80(3):1025–38.10.3233/JAD-201431 33646164
29.Jiao M Ding Z Huang C Xu Y Zhong B Chen H The effects of computerized cognitive training via tablet and computer platforms on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis Behav Sci 2025 16 1 40 41594981 10.3390/bs16010040 Jiao M, Ding Z, Huang C, Xu Y, Zhong B, Chen H. The effects of computerized cognitive training via tablet and computer platforms on cognitive function in patients with mild cognitive impairment: a systematic review and meta-analysis. Behav Sci. 2025;16(1):40.10.3390/bs16010040 PMC12837966 41594981
30.Gates NJ, Vernooij RW, Di Nisio M, Karim S, March E, Martinez G, et al. Computerised cognitive training for preventing dementia in people with mild cognitive impairment. Cochrane Database Syst Rev. 2019;3: CD012279.10.1002/14651858.CD012279.pub2 PMC6415132 30864747
31.Book S Jank M Pendergrass A Graessel E Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial Trials 2022 23 1 1 13 10.1186/s13063-022-06152-9 PMC9069424 35513855 Book S, Jank M, Pendergrass A, Graessel E. Individualised computerised cognitive training for community-dwelling people with mild cognitive impairment: study protocol of a completely virtual, randomised, controlled trial. Trials. 2022;23(1):1–13.10.1186/s13063-022-06152-9 PMC9069424 35513855
32.Graessel E Jank M Scheerbaum P Scheuermann J-S Pendergrass A Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study) BMC Med 2024 22 1 1 15 10.1186/s12916-024-03647-x PMC11481801 39407328 Graessel E, Jank M, Scheerbaum P, Scheuermann J-S, Pendergrass A. Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study). BMC Med. 2024;22(1):1–15.10.1186/s12916-024-03647-x PMC11481801 39407328
33.Dalile B, Kim C, Challinor A, Geurts L, Gibney ER, Galdos MV, et al. The EAT-Lancet reference diet and cognitive function across the life course. Lancet Planet Health. 2022;6(9):e749–59.10.1016/S2542-5196(22)00123-1 36087605
34.Puri S Shaheen M Grover B Nutrition and cognitive health: a life course approach Front Public Health 2023 11 1023907 37050953 10.3389/fpubh.2023.1023907 Puri S, Shaheen M, Grover B. Nutrition and cognitive health: a life course approach. Front Public Health. 2023;11:1023907.10.3389/fpubh.2023.1023907 PMC10083484 37050953
35.Lu Y Yuan H Li Y Liu Y Li R Diao Y Effects of nutritional interventions on cognitive function in adult cancer survivors: a systematic review J Clin Nurs 2024 33 11 4227 53 39021041 10.1111/jocn.17371 Lu Y, Yuan H, Li Y, Liu Y, Li R, Diao Y, et al. Effects of nutritional interventions on cognitive function in adult cancer survivors: a systematic review. J Clin Nurs. 2024;33(11):4227–53.10.1111/jocn.17371 39021041
36.Muth A-K Park SQ The impact of dietary macronutrient intake on cognitive function and the brain Clin nutr 2021 40 6 3999 4010 34139473 10.1016/j.clnu.2021.04.043 Muth A-K, Park SQ. The impact of dietary macronutrient intake on cognitive function and the brain. Clin nutr. 2021;40(6):3999–4010.10.1016/j.clnu.2021.04.043 34139473
37.Morris MC Tangney CC Wang Y Sacks FM Barnes LL Bennett DA Aggarwal NT: MIND diet slows cognitive decline with aging Alzheimer’s & dementia 2015 11 9 1015 22 10.1016/j.jalz.2015.04.011 PMC4581900 26086182 Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA. Aggarwal NT: MIND diet slows cognitive decline with aging. Alzheimer’s & dementia. 2015;11(9):1015–22.10.1016/j.jalz.2015.04.011 PMC4581900 26086182
38.Scarmeas N Stern Y Tang M-X Mayeux R Luchsinger JA Mediterranean diet and risk for Alzheimer’s disease Ann Neurol 2006 59 6 912 21 16622828 10.1002/ana.20854 Scarmeas N, Stern Y, Tang M-X, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006;59(6):912–21.10.1002/ana.20854 PMC3024594 16622828
39.Tangney CC Li H Wang Y Barnes L Schneider JA Bennett DA Relation of DASH-and Mediterranean-like dietary patterns to cognitive decline in older persons Neurology 2014 83 16 1410 16 25230996 10.1212/WNL.0000000000000884 Tangney CC, Li H, Wang Y, Barnes L, Schneider JA, Bennett DA, et al. Relation of DASH-and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014;83(16):1410–16.10.1212/WNL.0000000000000884 PMC4206157 25230996
40.Loughrey DG Lavecchia S Brennan S Lawlor BA Kelly ME The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis Adv nutr 2017 8 4 571 86 28710144 10.3945/an.117.015495 Loughrey DG, Lavecchia S, Brennan S, Lawlor BA, Kelly ME. The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. Adv nutr. 2017;8(4):571–86.10.3945/an.117.015495 PMC5502874 28710144
41.Kjeldsen EW Frikke-Schmidt R Causal cardiovascular risk factors for dementia: insights from observational and genetic studies Cardiovasc Res 2025 121 4 537 49 39498825 10.1093/cvr/cvae235 Kjeldsen EW, Frikke-Schmidt R. Causal cardiovascular risk factors for dementia: insights from observational and genetic studies. Cardiovasc Res. 2025;121(4):537–49.10.1093/cvr/cvae235 PMC12054631 39498825
42.Yokoyama Y Barnard ND Levin SM Watanabe M Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis Cardiovasc Diagn Ther 2014 4 5 373 25414824 10.3978/j.issn.2223-3652.2014.10.04 Yokoyama Y, Barnard ND, Levin SM, Watanabe M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther. 2014;4(5):373.10.3978/j.issn.2223-3652.2014.10.04 PMC4221319 25414824
43.Barnard ND Cohen J Jenkins DJ Turner-McGrievy G Gloede L Jaster B Talpers S: a low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes Diabetes Care 2006 29 8 1777 83 16873779 10.2337/dc06-0606 Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Jaster B, et al. Talpers S: a low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29(8):1777–83.10.2337/dc06-0606 16873779
44.Ornish D Brown SE Scherwitz LW Billings JH Armstrong WT Ports TA Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial Lancet 1990 336 8708 129 33 1973470 10.1016/0140-6736(90)91656-U Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 1990;336(8708):129–33.10.1016/0140-6736(90)91656-u 1973470
45.Esselstyn Jr CB: Resolving the coronary artery disease epidemic through plant-based nutrition. Prev Cardiol. 2001;4(4):171–77.10.1111/j.1520-037x.2001.00538.x 11832674
46.Barnard ND Levin SM Yokoyama Y: a systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets J Acad nutr Diet 2015 115 6 954 69 25620754 10.1016/j.jand.2014.11.016 Barnard ND, Levin SM. Yokoyama Y: a systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets. J Acad nutr Diet. 2015;115(6):954–69.10.1016/j.jand.2014.11.016 25620754
47.Foster GD Wyatt HR Hill JO McGuckin BG Brill C Mohammed BS A randomized trial of a low-carbohydrate diet for obesity NEJM Evid 2003 348 21 2082 90 10.1056/NEJMoa022207 12761365 Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, et al. A randomized trial of a low-carbohydrate diet for obesity. NEJM Evid. 2003;348(21):2082–90.10.1056/NEJMoa022207 12761365
48.Song M Fung TT Hu FB Willett WC Longo VD Chan AT Association of animal and plant protein intake with all-cause and cause-specific mortality JAMA Intern Med 2016 176 10 1453 63 27479196 10.1001/jamainternmed.2016.4182 Song M, Fung TT, Hu FB, Willett WC, Longo VD, Chan AT, et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med. 2016;176(10):1453–63.10.1001/jamainternmed.2016.4182 PMC5048552 27479196
49.Jacobs DR Jr, Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. Am J Clin nutr. 2003;78(3):508S–13S.10.1093/ajcn/78.3.508S 12936941
50.Salas-Salvadó J Bulló M Estruch R Ros E Covas M-I Ibarrola-Jurado N Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial Ann Intern Med 2014 160 1 1 10 24573661 10.7326/M13-1725 Salas-Salvadó J, Bulló M, Estruch R, Ros E, Covas M-I, Ibarrola-Jurado N, et al. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med. 2014;160(1):1–10.10.7326/M13-1725 24573661
51.Cunningham C Hennessy E Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research Alzheimer’s Res & Ther 2015 7 1 33 10.1186/s13195-015-0117-2 PMC4369837 25802557 Cunningham C, Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimer’s Res & Ther. 2015;7(1):33.10.1186/s13195-015-0117-2 PMC4369837 25802557
52.Prokopidis K, Giannos P, Ispoglou T, Witard OC, Isanejad M. Dietary fiber intake is associated with cognitive function in older adults: data from the national health and nutrition examination survey. Am J Med. 2022;135(8):e257–62.10.1016/j.amjmed.2022.03.022 35367443
53.Cha S Bell L Williams CM The relationship between mushroom intake and cognitive performance: an epidemiological study in the European investigation of Cancer-Norfolk cohort (EPIC-Norfolk) Nutrients 2024 16 3 353 38337638 10.3390/nu16030353 Cha S, Bell L, Williams CM. The relationship between mushroom intake and cognitive performance: an epidemiological study in the European investigation of Cancer-Norfolk cohort (EPIC-Norfolk). Nutrients. 2024;16(3):353.10.3390/nu16030353 PMC10857520 38337638
54.Yang Y Zhu D Qi R Chen Y Sheng B Zhang X Association between intake of edible mushrooms and algae and the risk of cognitive impairment in Chinese older adults Nutrients 2024 16 5 637 38474765 10.3390/nu16050637 Yang Y, Zhu D, Qi R, Chen Y, Sheng B, Zhang X. Association between intake of edible mushrooms and algae and the risk of cognitive impairment in Chinese older adults. Nutrients. 2024;16(5):637.10.3390/nu16050637 PMC10934229 38474765
55.Morris MC, Wang Y, Barnes LL, Bennett DA, Dawson-Hughes B, Booth SL. Nutrients and bioactives in green leafy vegetables and cognitive decline: prospective study. Neurology. 2018;90(3):e214–22.10.1212/WNL.0000000000004815 PMC5772164 29263222
56.Ornish D Madison C Kivipelto M Kemp C McCulloch CE Galasko D Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial Alzheimer’s Res & Ther 2024 16 1 122 10.1186/s13195-024-01482-z PMC11157928 38849944 Ornish D, Madison C, Kivipelto M, Kemp C, McCulloch CE, Galasko D, et al. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial. Alzheimer’s Res & Ther. 2024;16(1):122.10.1186/s13195-024-01482-z PMC11157928 38849944
57.Scheerbaum P Graessel E Boesl S Hanslian E Kessler CS Scheuermann J-S Are protective activities and limitations in practical skills of daily living associated with the cognitive performance of people with mild cognitive impairment? Baseline results from the BrainFit-nutrition study Nutrients 2023 15 16 3519 37630709 10.3390/nu15163519 Scheerbaum P, Graessel E, Boesl S, Hanslian E, Kessler CS, Scheuermann J-S. Are protective activities and limitations in practical skills of daily living associated with the cognitive performance of people with mild cognitive impairment? Baseline results from the BrainFit-nutrition study. Nutrients. 2023;15(16):3519.10.3390/nu15163519 PMC10459420 37630709
58.Boesl S Scheerbaum P Graessel E Kessler C Scheuermann J-S My patient might be depressed-can I still screen for MCI? Exploring cognitive performance on the MoCA in older people screened for depressive symptoms with the PHQ-9 BMC Geriatrics 2025 25 1 374 10.1186/s12877-025-06004-6 PMC12102864 40413417 Boesl S, Scheerbaum P, Graessel E, Kessler C, Scheuermann J-S. My patient might be depressed-can I still screen for MCI? Exploring cognitive performance on the MoCA in older people screened for depressive symptoms with the PHQ-9. BMC Geriatrics. 2025;25(1):374.10.1186/s12877-025-06004-6 PMC12102864 40413417
59.Donath C Gräßel E Scheuermann J-S Bösl S Scheerbaum P Manchmal trink ich auch Wasser … -Alkoholkonsum von Menschen mit leichter kognitiver Beeinträchtigung Psychiatr Prax 2024 51 1 39 44 37673095 10.1055/a-2133-4268 Donath C, Gräßel E, Scheuermann J-S, Bösl S, Scheerbaum P. Manchmal trink ich auch Wasser … -Alkoholkonsum von Menschen mit leichter kognitiver Beeinträchtigung. Psychiatr Prax. 2024;51(1):39–44.10.1055/a-2133-4268 37673095
60.Scheuermann J-S, Graessel E, Schmitt M, Scheerbaum P. User experience with two computerized cognitive intervention programs for people with mild cognitive impairment. BMC Geriatrics. 2026;26(29).10.1186/s12877-025-06767-y PMC12784485 41372834
61.Hanslian E Dell’oro M Schiele JK Kandil FI Hasanbasic D Henn C Effects of nutritional counseling on dietary patterns in patients with mild cognitive impairment: insights from the BrainFit-nutrition study Front nutr 2025 12 1536939 40357042 10.3389/fnut.2025.1536939 Hanslian E, Dell’oro M, Schiele JK, Kandil FI, Hasanbasic D, Henn C, et al. Effects of nutritional counseling on dietary patterns in patients with mild cognitive impairment: insights from the BrainFit-nutrition study. Front nutr. 2025;12:1536939.10.3389/fnut.2025.1536939 PMC12066778 40357042
62.Scheerbaum P Book S Jank M Hanslian E Dell’oro M Schneider J Computerised cognitive training tools and online nutritional group counselling for people with mild cognitive impairment: study protocol of a completely digital, randomised, controlled trial BMJ Open 2022 12 7 1 13 10.1136/bmjopen-2021-060473 PMC9252202 35777882 Scheerbaum P, Book S, Jank M, Hanslian E, Dell’oro M, Schneider J, et al. Computerised cognitive training tools and online nutritional group counselling for people with mild cognitive impairment: study protocol of a completely digital, randomised, controlled trial. BMJ Open. 2022;12(7):1–13.10.1136/bmjopen-2021-060473 PMC9252202 35777882
63.Hauner H, Beyer-Reiners E, Bischoff G, Breidenassel C, Ferschke M, Gebhardt A, et al. Leitfaden Ernährungstherapie Klinik und Prax (LEKuP). Aktuelle Ernährungsmedizin. 2019;44(6):384–419.
64.Nasreddine ZS Phillips NA Bedirian V Charbonneau S Whitehead V Collin I The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 2005 53 4 695 99 15817019 10.1111/j.1532-5415.2005.53221.x Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–99.10.1111/j.1532-5415.2005.53221.x 15817019
65.Freitas S Simoes MR Alves L Santana I Montreal cognitive assessment: validation study for mild cognitive impairment and alzheimer disease Alz Dis Assoc Dis 2013 27 1 37 43 10.1097/WAD.0b013e3182420bfe 22193353 Freitas S, Simoes MR, Alves L, Santana I. Montreal cognitive assessment: validation study for mild cognitive impairment and alzheimer disease. Alz Dis Assoc Dis. 2013;27(1):37–43.10.1097/WAD.0b013e3182420bfe 22193353
66.Larner AJ Screening utility of the montreal cognitive assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatrics 2012 24 3 391 96 10.1017/S1041610211001839 22014176 Larner AJ. Screening utility of the montreal cognitive assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatrics. 2012;24(3):391–96.10.1017/S1041610211001839 22014176
67.Dong Y Lee WY Basri NA Collinson SL Merchant RA Venketasubramanian N The Montreal cognitive assessment is superior to the mini-mental state examination in detecting patients at higher risk of dementia Int Psychogeriatrics 2012 24 11 1749 55 10.1017/S1041610212001068 22687278 Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal cognitive assessment is superior to the mini-mental state examination in detecting patients at higher risk of dementia. Int Psychogeriatrics. 2012;24(11):1749–55.10.1017/S1041610212001068 22687278
68.O’caoimh R Timmons S Molloy DW Screening for mild cognitive impairment: comparison of “MCI specific” screening instruments J Alzheimers Dis 2016 51 2 619 29 26890758 10.3233/JAD-150881 O’caoimh R, Timmons S, Molloy DW. Screening for mild cognitive impairment: comparison of “MCI specific” screening instruments. J Alzheimers Dis. 2016;51(2):619–29.10.3233/JAD-150881 PMC4927818 26890758
69.Thomann AE Berres M Goettel N Steiner LA Monsch AU Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal cognitive assessment Alzheimer’s Res & Ther 2020 12 1 39 10.1186/s13195-020-00603-8 PMC7140337 32264975 Thomann AE, Berres M, Goettel N, Steiner LA, Monsch AU. Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal cognitive assessment. Alzheimer’s Res & Ther. 2020;12(1):39.10.1186/s13195-020-00603-8 PMC7140337 32264975
70.Arevalo-Rodriguez I, Smailagic N, Roque IFM, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-mental state examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;3: CD010783.10.1002/14651858.CD010783.pub2 PMC6464748 25740785
71.Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-mental state examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;1): CD011145.10.1002/14651858.CD011145.pub2 PMC8812342 26760674
72.Munro Cullum C, Hynan LS, Grosch M, Parikh M, Weiner MF. Teleneuropsychology: evidence for video teleconference-based neuropsychological assessment. Journal of the International Neuropsychological Society. 2014: 1028–33, 20(10).10.1017/S1355617714000873 PMC4410096 25343269
73.Timpano F, Pirrotta F, Bonanno L, Marino S, Marra A, Bramanti P, et al. Videoconference-based mini mental state examination: a validation study. Telemedicine and e-Health. 2013: 931–37, 19 (12).10.1089/tmj.2013.0035 24073900
74.Kroenke K Spitzer RL Williams JBW Löwe B The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review Gener Hosp Psychiatry 2010 32 4 345 59 10.1016/j.genhosppsych.2010.03.006 20633738 Kroenke K, Spitzer RL, Williams JBW, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gener Hosp Psychiatry. 2010;32(4):345–59.10.1016/j.genhosppsych.2010.03.006 20633738
75.Gilbody S Richards D Barkham M Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM Br J Gen Pract 2007 57 541 650 52 17688760 Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract. 2007;57(541):650–52.PMC2099671 17688760
76.International Standard Classification of Education (ISCED-. 2011) [https://metadaten.bibb.de/de/classification/detail/39].
77.Lippert T Maas R Fromm MF Luttenberger K Kolominsky-Rabas P Pendergrass A Impact of sedating drugs on falls resulting injuries among people with dementia in a nursing home setting Gesundheitswesen 2020 82 1 14 22 31962367 10.1055/a-1071-7911 Lippert T, Maas R, Fromm MF, Luttenberger K, Kolominsky-Rabas P, Pendergrass A, et al. Impact of sedating drugs on falls resulting injuries among people with dementia in a nursing home setting. Gesundheitswesen. 2020;82(1):14–22.10.1055/a-1071-7911 31962367
78.Quan H Li B Couris CM Fushimi K Graham P Hider P Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries Am J Epidemiol 2011 173 6 676 82 21330339 10.1093/aje/kwq433 Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.10.1093/aje/kwq433 21330339
79.Graessel E Jank M Greiner S Stemmler M First validation of the computerized cognitive test battery (CCTB) on the short cognitive performance test (SKT) and the montreal cognitive assessment (MoCA) in terms of convergent and divergent validity in individuals aged 60 years and older 2024 ErlangenOpen FAUGraessel E, Jank M, Greiner S, Stemmler M. First validation of the computerized cognitive test battery (CCTB) on the short cognitive performance test (SKT) and the montreal cognitive assessment (MoCA) in terms of convergent and divergent validity in individuals aged 60 years and older. Erlangen: Open FAU; 2024.
80.Van Dyck CH Swanson CJ Aisen P Bateman RJ Chen C Gee M Lecanemab in early Alzheimer’s disease NEJM Evid 2023 388 1 9 21 10.1056/NEJMoa2212948 36449413 Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer’s disease. NEJM Evid. 2023;388(1):9–21.10.1056/NEJMoa2212948 36449413
81.Cohen J Statistical power analysis for the behavioral sciences 1988 2ndHillsdaleErlbaum AssociatesCohen J. Statistical power analysis for the behavioral sciences. 2nd. Hillsdale: Erlbaum Associates; 1988.
82.Yu J-T Xu W Tan C-C Andrieu S Suckling J Evangelou E Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials J Neurol, Neurosurg Psychiatry 2020 91 11 1201 09 32690803 10.1136/jnnp-2019-321913 Yu J-T, Xu W, Tan C-C, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol, Neurosurg Psychiatry. 2020;91(11):1201–09.10.1136/jnnp-2019-321913 PMC7569385 32690803
83.Field A Discovering statistics using IBM SPSS statistics 2024 6 ednSAGE Publications LimitedField A. Discovering statistics using IBM SPSS statistics. 6 edn. SAGE Publications Limited; 2024.
84.Pituch KA Stevens JP Applied multivariate statistics for the social sciences: analyses with SAS and IBM’s SPSS 2015 6 ednNew YorkRoutledge10.4324/9781315814919 Pituch KA, Stevens JP. Applied multivariate statistics for the social sciences: analyses with SAS and IBM’s SPSS. 6 edn. New York: Routledge; 2015.
85.Aiello EN Solca F Torre S Curti B De Luca G Bonetti R Reliable change indices for the Italian version of the montreal cognitive assessment (MoCA) in non-demented Parkinson’s disease patients BMC Neurol 2024 24 1 427 10.1186/s12883-024-03920-9 39497078 Aiello EN, Solca F, Torre S, Curti B, De Luca G, Bonetti R, et al. Reliable change indices for the Italian version of the montreal cognitive assessment (MoCA) in non-demented Parkinson’s disease patients. BMC Neurol. 2024;24(1):427.10.1186/s12883-024-03920-9 PMC11533291 39497078
86.Cooley SA Heaps JM Bolzenius JD Salminen LE Baker LM Scott SE Longitudinal change in performance on the Montreal cognitive assessment in older adults Clin Neuropsychol 2015 29 6 824 35 26373627 10.1080/13854046.2015.1087596 Cooley SA, Heaps JM, Bolzenius JD, Salminen LE, Baker LM, Scott SE, et al. Longitudinal change in performance on the Montreal cognitive assessment in older adults. Clin Neuropsychol. 2015;29(6):824–35.10.1080/13854046.2015.1087596 PMC4644436 26373627
87.Kopecek M Bezdicek O Sulc Z Lukavsky J Stepankova H Montreal cognitive assessment and mini-mental state examination reliable change indices in healthy older adults Int J Geriatric Psychiatry 2017 32 8 868 75 10.1002/gps.4539 27352935 Kopecek M, Bezdicek O, Sulc Z, Lukavsky J, Stepankova H. Montreal cognitive assessment and mini-mental state examination reliable change indices in healthy older adults. Int J Geriatric Psychiatry. 2017;32(8):868–75.10.1002/gps.4539 27352935
88.Wang C, Nester CO, Chang K, Rabin LA, Ezzati A, Lipton RB, et al. Tracking cognition with the T-MoCA in a racially/ethnically diverse older adult cohort. Alzheimer’s Dementia: Diagnosis, Assess Disease Monit. 2023;15(1):e12410.10.1002/dad2.12410 PMC10026378 36950700
89.Grande G Cucumo V Cova I Ghiretti R Maggiore L Lacorte E Reversible mild cognitive impairment: the role of comorbidities at baseline evaluation J Alzheimers Dis 2016 51 1 57 67 26836169 10.3233/JAD-150786 Grande G, Cucumo V, Cova I, Ghiretti R, Maggiore L, Lacorte E, et al. Reversible mild cognitive impairment: the role of comorbidities at baseline evaluation. J Alzheimers Dis. 2016;51(1):57–67.10.3233/JAD-150786 26836169
90.Gao Q Gwee X Feng L Nyunt MSZ Feng L Collinson SL Mild cognitive impairment reversion and progression: rates and predictors in community-living older persons in the Singapore longitudinal ageing studies cohort Dementia Geriatric Cognit Disord Extra 2018 8 2 226 37 10.1159/000488936 PMC6047537 30022996 Gao Q, Gwee X, Feng L, Nyunt MSZ, Feng L, Collinson SL, et al. Mild cognitive impairment reversion and progression: rates and predictors in community-living older persons in the Singapore longitudinal ageing studies cohort. Dementia Geriatric Cognit Disord Extra. 2018;8(2):226–37.10.1159/000488936 PMC6047537 30022996
91.McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z. Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms. Neurology. 2022;98(21):e2132–e 2139.10.1212/WNL.0000000000200256 PMC9169943 35351783
92.Koepsell TD Monsell SE Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis Neurology 2012 79 15 1591 98 23019264 10.1212/WNL.0b013e31826e26b7 Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012;79(15):1591–98.10.1212/WNL.0b013e31826e26b7 PMC3475624 23019264
93.Yu H-H Tan L Jiao M-J Lv Y-J Zhang X-H Tan C-C Initiative AsDN: dissecting the clinical and pathological prognosis of MCI patients who reverted to normal cognition: a longitudinal study BMC Med 2025 23 1 260 40325426 10.1186/s12916-025-04092-0 Yu H-H, Tan L, Jiao M-J, Lv Y-J, Zhang X-H, Tan C-C, et al. Initiative AsDN: dissecting the clinical and pathological prognosis of MCI patients who reverted to normal cognition: a longitudinal study. BMC Med. 2025;23(1):260.10.1186/s12916-025-04092-0 PMC12054060 40325426
94.Canevelli M Grande G Lacorte E Quarchioni E Cesari M Mariani C Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and meta-analysis J Am Med Dir Assoc 2016 17 10 943 48 27502450 10.1016/j.jamda.2016.06.020 Canevelli M, Grande G, Lacorte E, Quarchioni E, Cesari M, Mariani C, et al. Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and meta-analysis. J Am Med Dir Assoc. 2016;17(10):943–48.10.1016/j.jamda.2016.06.020 27502450
95.Petersen RC Mild cognitive impairment as a diagnostic entity J Intern Med 2004 256 3 183 94 15324362 10.1111/j.1365-2796.2004.01388.x Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.10.1111/j.1365-2796.2004.01388.x 15324362
96.Couch E, Lawrence V, Prina M. Outcomes tested in non-pharmacological interventions in mild cognitive impairment and mild dementia: a scoping review. BMJ Open. 2020;10(4):e035980.10.1136/bmjopen-2019-035980 PMC7204934 32317262
97.Andrews V Zammit G O’Leary F: dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews nutr Rev 2023 81 11 1462 89 37027832 10.1093/nutrit/nuad013 Andrews V, Zammit G. O’Leary F: dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. nutr Rev. 2023;81(11):1462–89.10.1093/nutrit/nuad013 PMC10563860 37027832
98.Solfrizzi V Agosti P Lozupone M Custodero C Schilardi A Valiani V Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: a systematic review Neurosci Biobehav Rev 2018 95 480 98 30395922 10.1016/j.neubiorev.2018.10.022 Solfrizzi V, Agosti P, Lozupone M, Custodero C, Schilardi A, Valiani V, et al. Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: a systematic review. Neurosci Biobehav Rev. 2018;95:480–98.10.1016/j.neubiorev.2018.10.022 30395922
99.Choi H Shin J Kim JH Lee B-K Lee S-K Ahn M-E Digital therapeutics for patients with mild cognitive impairment: design of a Mobile health program Electronics 2024 13 19 3892 10.3390/electronics13193892 Choi H, Shin J, Kim JH, Lee B-K, Lee S-K, Ahn M-E, et al. Digital therapeutics for patients with mild cognitive impairment: design of a Mobile health program. Electronics. 2024;13(19):3892.
100.Salzman T, Sarquis-Adamson Y, Son S, Montero-Odasso M, Fraser S. Associations of multidomain interventions with improvements in cognition in mild cognitive impairment: a systematic review and meta-analysis. JAMA Network Open. 2022;5(5):e226744.10.1001/jamanetworkopen.2022.6744 PMC9066287 35503222
101.Chuang I-C Chiau H-Y Liao W-W Wu Y-R Chang C-H Wu C-Y Effects of computer-based cognitive training combined with physical training for older adults with cognitive impairment: a four-arm randomized controlled trial Digit Health 2023 9 20552076231203633 37744745 10.1177/20552076231203633 Chuang I-C, Chiau H-Y, Liao W-W, Wu Y-R, Chang C-H, Wu C-Y. Effects of computer-based cognitive training combined with physical training for older adults with cognitive impairment: a four-arm randomized controlled trial. Digit Health. 2023;9:20552076231203633.10.1177/20552076231203633 PMC10515553 37744745
102.Choi HY, Kim YJ, Son D-S, Ahn ME, Lee S-K. Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial. Scientific reports. 2025;15(1):41141.10.1038/s41598-025-24865-0 PMC12635255 41266554
Come citare questo studio
Julia-Sophia Scheuermann, Elmar Graessel, Etienne Hanslian, Julia Schiele, Melanie Dell'oro, Martin Schmitt, Michael Jeitler, Christian S Kessler. (2026). Computerised cognitive training combined with nutritional counseling in mild cognitive impairment - results of a 2 × 2 factorial randomized controlled trial (BrainFit-nutrition study).. Alzheimer's research & therapy. DOI: 10.1186/s13195-026-02255-6
Consulta la pubblicazione originale ↗